Know Labs, Inc. Appoints Donna Ryan to Advisory Board
September 11, 2019 at 06:30 pm IST
Share
Know Labs, Inc. announced that Donna Ryan, RN, RD, MPH, CDE has joined its Medical, Scientific and Regulatory Advisory Board. The Know Labs Advisory Board was formed to provide counsel and guidance to the Company and its senior management as they work toward FDA approval and marketing of their non-invasive UBAND Continuous Glucose Monitor (CGM). The Advisory Board is chaired by Know Labs Chief Medical Officer, James (Andy) Anderson, M.D. Ms. Ryan brings twenty years of experience in diabetes education and management and is passionate about helping underserved communities manage their diabetes. Her extensive knowledge in diabetes management and real-world experience will greatly assist Know Labs in bringing its UBAND CGM to market. Currently, Ms. Ryan serves as Director of Population Health for Ascension Sacred Heart Health System, Pensacola, Florida and manages four diabetes outpatient and inpatient programs within Ascension Health, giving her a practical perspective on diabetes care and management.
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Companyâs Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Companyâs trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.